Philanthropy We extend our deepest thanks to the many loyal donors, who support our mission to advance medical science, develop new treatments and cures, train new generations of physicianscientists, and improve the health of those in Miami, South Florida and beyond. Your gifts support over 326 physicians whose appointments in the Department of Medicine are represented by the 15 Divisions in this report.
EXTRAORDINARY GIFT NAMES DIVISION OF NEPHROLOGY AND HYPERTENSION Longtime donors, Peggy and Harold Katz, committed $10 million to ensure long-term progress in research, education, and clinical achievements in the The Katz Family Division of Nephrology and Hypertension. The division has been named in their honor with approval by the Executive Committee of the University’s Board of Trustees. “This gift will help us advance to the forefront of clinical and experimental innovation,” said Roy E. Weiss, M.D., Ph.D., chair of the Department of Medicine and the Kathleen and Stanley Glaser Distinguished Chair in Medicine. Anticipated initiatives include the creation of an interdisciplinary Renal Disease Center to translate discovery research into patient care, research into rare diseases such as adult polycystic kidney diseases (ADPKD), further emphasis on drug discovery, and a push to expand interest in nephrology among undergraduate students and medical students. The gift will also create two professorships and establish the “David Roth, M.D., Endowed Chair in Transplant Nephrology,” which creates a named legacy for the former chief of the division, who is a 33-year member of the UM faculty. “It is a remarkable honor and I am very humbled by it,” said Roth, William Way Anderson Professor of Nephrology and director of clinical services. “I have dedicated my life to teaching and research in an academic setting. To have this type of recognition from a grateful patient like Peggy Katz is a real honor because it exemplifies what I’ve tried to accomplish.” D epartmen t o f Medic in e C h air man ’s R e po r t 2017
Over the past decade, the Katz family has made other generous contributions that have led to the growth of the division’s scientific program and investigators. They helped establish The Peggy and Harold Katz Family Drug Discovery Center, which conducts groundbreaking research to improve the lives of patients with kidney disease and is led by Director Alessia Fornoni, M.D., Ph.D., a professor of medicine who is also the Peggy and Harold Katz Family Chair, and the newly named chief of The Katz Family Division of Nephrology and Hypertension
From left, Alessia Fornoni, M.D., Ph.D., Peggy Katz and David Roth, M.D.
GIFTS AT WORK Thanks to the generosity of our friends and grateful patients, alumni, and faculty, the department is able to offer six annually endowed lectures presented by distinguished scholars, who are researching some of the most challenging health care problems we face today. More about two such lectures below, and a recap of this year’s Dr. Robert J. Myerburg Endowed Lecture in the Cardiovascular Medicine section of this annual report. THE CUNIO-RICHARDSON ENDOWED LECTURE IN
From left, William W. Anderson, M.D., former UM clinical faculty, who helped spearhead both the memorial lecture and community funding to support it, was on hand to greet Joseph Bonventre, M.D.
NEPHROLOGY, presented by Joseph V. Bonventre,
M.D., Ph.D., Samuel A. Levine Professor of Medicine, Harvard Medical School, focused on “Acute Kidney Injury: Adaptive and Maladaptive Repair.” The lecture is administered thru the longtime collaboration between the National Kidney Foundation of Florida and UM’s Katz Family Division of Nephrology and Hypertension. The NKFF’s donations have totaled nearly $550K in the last 56 years, and have supported both research and education. THE SUZANNE R AND LAWRENCE M.
From left, Gary D. Hammer, M.D., Ph.D. (University of Michigan) and Lawrence M. Fishman, M.D.
FISHMAN ENDOWED ENDOCRINOLOGY VISITING PROFESSORSHIP, as supplemented by a generous
gift from Tisch and Stuart R. Weiss, M.D. ’71, made this year’s Fishman Lecture and Endocrine Conference possible. Gary D. Hammer, M.D., Ph.D., Millie Schembechler Professor of Adrenal Cancer and Director, Endocrine Oncology Program at the University of Michigan, addressed “Adrenocortical Carcinoma: Challenges & the Future of Integrated Care.” 33